30 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Debattista, Psychiatrist in Stanford, CA?
Dr. Charles Debattista, MD is a Psychiatrist, who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 30 years and is board certified. Dr. Debattista graduated from University of California and completed his residency at Stanford Univ Hosp, Psychiatry. Dr. Debattista is fluent in English, and is currently seeing new patients. Dr. Debattista’s practice accepts Kaiser Permanente, Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Debattista’s office at (650) 498-9111.
Where did Dr. Debattista go to medical school and complete their residency?
Fellowship: Stanford University Medical Center CA
Residency: Stanford Univ Hosp, Psychiatry | Stanford University Hospital | Stanford University Medical Center | Stanford University Program
Medical School: University of Ca, San Francisco, Sch of Med, San Francisco Ca | University of California
Is Dr. Debattista board certified as a Psychiatrist?
Yes, Dr. Charles Debattista, MD is board certified by the American Board of Psychiatry and Neurology , American Board of Psychiatry and Neurology since 1995
What languages does Dr. Debattista speak?
Dr. Debattista and their clinical team can communicate with patients in the following languages:
English
What conditions does a Psychiatrist like Dr. Debattista typically treat?
As a Psychiatrist, Dr. Debattista diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Debattista. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Recurrent Severe Depression
- Moderate Recurrent Major Depression
- Recurrent Depression in Partial Remission
- Depression
- Chronic severe depression
- Repeated severe depressive episodes
- Clinical depression
- Moderate chronic depression
- Moderate recurring depression
- Moderate depressive episodes
- Improving recurrent depression
- Resolving recurrent depressive symptoms
- Partial recovery from recurrent depression
- Major depressive disorder
- Mood disorder
ICD-10 Codes:
- F332: Major depressive disorder, recurrent severe without psychotic features
- F331: Major depressive disorder, recurrent, moderate
- F3341: Major depressive disorder, recurrent, in partial remission
- F32A: Depression, unspecified
What procedures does a Psychiatrist like Dr. Debattista typically perform?
As a Psychiatrist, procedures performed by Dr. Charles Debattista may include:
- Child Psychiatry Consultation
- Child Psychiatry Follow Up
- Cognitive Behavioral Therapy (CBT)
- Couples Therapy
- Electroconvulsive Therapy (ECT)
- Hypnotherapy
- Inpatient Psychiatric Services
- Ketamine Infusion
Please contact Dr. Debattista's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Debattista accept my insurance?
Dr. Debattista accepts most major insurance plans. Important: Please call our office at (650) 498-9111 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Debattista accept in Stanford, CA?
Dr. Debattista in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Kaiser Permanente
Medicaid
Medicare
UnitedHealth Group
Unknown
Valley Health Plan
View All Insurances
Where is Dr. Debattista's office located?
Dr. Charles Debattista's Primary Practice
300 Pasteur Dr
Stanford, CA 94305
(650) 498-9111
Recognitions
Awards
America's Best Doctors
Psychiatry, Best Doctors
Review Article of the Year, Primary Psychiatry
Teacher of the Year, Dept. Of Psychiatry
Publications
Measuring severe adverse events
, 2012
The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression
, 2011
Safety considerations of the use of second generation antipsychotics
, 2010
Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function
, 2009
A multisite trial of mifepristone for the treatment of psychotic depression
, 2009
Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression
, 2009
Sildefil treatment of women with antidepressant-associated sexual dysfunction - A r
, 2008
Depression and smoking cessation: does the evidence support psychiatric practice?
, 2007
Modafinil augmentation of selective serotonin reuptake inhibitor therapy
, 2007
Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major
, 2006
The neuropsychological profile of psychotic major depression and its relation to cortisol
, 2006
The efficacy of mifepristone in the reduction
, 2006
Augmentation and combition strategies for depression
, 2006
The use of mifepristone in the treatment of neuropsychiatric disorders
, 2006
Modafinil augmentation of SSRI therapy in patients with major depressive disorder
, 2006
Detecting psychotic major depression using psychiatric rating scales
, 2006
Update on augmentation of antidepressant response in resistant depression.
, 2005
The efficacy of divalproex sodium in the treatment of agitation associated with major depression
, 2005
A placebo-controlled, randomized
, 2005
C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease.
, 2005
Executive dysfunction in major depressive disorder.
, 2005
A multicenter, placebo
, 2005
HPA axis activation in major depression and response to fluoxetine: a pilot study
, 2004
A prospective trial of modafinil as an adjunctive treatment of major depression
, 2004
Seizure duration with remifentanil
, 2003
Adjunct modafinil for the short-term treatment of fatigue
, 2003
Safety of antidepressants in the elderly.
, 2003
A prospective trial of bupropion SR augmentation of partial
, 2003
The timing of electroconvulsive therapy
, 2003
Fetal heart rate decelerations during ECT-induced seizures: is it important?
, 2003
An open label trial of C-1073 (mifepristone) for psychotic major depression
, 2002
Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone
, 2002
Cortisol feedback during the HPA quiescent period in patients with major depression
, 2001
Is electroconvulsive therapy effective for the depressed patient
, 2001
Sertraline versus imipramine to prevent relapse in chronic depression
, 2001
Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia
, 2001
Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients
, 2000
24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major
, 2000
Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness
, 2000
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression
, 2000
Negative-pressure pulmory edema: A potential mazard in patients undergoing ECT
, 1999
The Texas Medication Algorithm Project
, 1999
Phenomenology and treatment of agitation
, 1999
ECT in dissociative identity disorder and comorbid depression
, 1998
Serotonergic synergism
, 1998
Developing treatment algorithms for unipolar depression in cyberspace
, 1998
Treatment of psychotic depression
, 1997
Development of obsessive symptoms during nefazodone treatment
, 1996
SUMATRIPTAN PROPHYLAXIS FOR POSTELECTROCONVULSIVE THERAPY HEADACHES
, 1995
PHYSICAL SYMPTOMS ASSOCIATED WITH PAROXETINE WITHDRAWAL
, 1995
What is Dr. Debattista's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Debattista's National Provider Identifier (NPI) number is 1982749941.
What common questions do patients ask about Dr. Debattista?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Debattista
What is Dr. Charles Debattista's specialty?
Dr. Debattista is a Psychiatrist near Stanford, CA.
What does a Psychiatrist do?
A Psychiatrist specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.